Clinical trial
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
NCT00072839 · Shire, Industry · Completed
Key facts
| NCT number | NCT00072839 |
|---|---|
| Title | Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease |
| Official title | A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | ALX-0600, placebo, teduglutide 0.05, teduglutide 0.2 mg, Teduglutide 0.05 dose, teduglutide 0.1 mg dose |
| Enrollment | 100 |
| Start date | Nov 12, 2003 |
| Primary completion | Jul 28, 2005 |
| Completion | Jul 28, 2005 |
| First posted | Nov 13, 2003 |
| Last update posted | May 25, 2021 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: